UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.570

Sortiert nach

Environmental assessment of an integrated adaptive system for the improvement of indoor visual comfort of existing buildings

Renewable energy, 2018-01, Vol.115, p.620-633

2018

Volltextzugriff (PDF)

Omalizumab for the management of refractory aquagenic pruritus

Journal of the European Academy of Dermatology and Venereology, 2023-11, Vol.37 (11), p.e1316-e1317

2023

Volltextzugriff (PDF)

Pharmacokinetic profile data of glycopyrronium bromide 1% cream beyond 2 weeks are important

British journal of dermatology (1951), 2021-08, Vol.185 (2), p.467-468

2021

Volltextzugriff (PDF)

BP-180-specific IgG antibodies: A potential useful candidate for early diagnosis of Bullous pemphigoid during anti-PD-1/anti-PDL-1 of melanoma patients

Medical hypotheses, 2021-12, Vol.157, p.110703-110703, Article 110703

2021

Volltextzugriff (PDF)

‘COVID vaccine arm’ may present after both mRNA vaccines vaccination

Journal of the European Academy of Dermatology and Venereology, 2021-12, Vol.35 (12), p.e867-e868

2021

Volltextzugriff (PDF)

Treatment of male genital lichen sclerosus with heterologous type I collagen

Clinical and experimental dermatology, 2020-04, Vol.45 (3), p.388-390

2020

Volltextzugriff (PDF)

Treatment of nail psoriasis with brodalumab: an open‐label unblinded study

Journal of the European Academy of Dermatology and Venereology, 2021-04, Vol.35 (4), p.e299-e301

2021

Volltextzugriff (PDF)

Stress and melanoma. Myth or reality?

British journal of dermatology (1951), 2020-10, Vol.183 (4), p.607-608

2020

Volltextzugriff (PDF)

Management Strategies Of Palmar Hyperhidrosis: Challenges And Solutions

Clinical, cosmetic and investigational dermatology, 2019-10, Vol.12, p.733-744

2019

Volltextzugriff (PDF)

Treatment of primary axillary hyperhidrosis with a cream formulation of oxybutynin chloride 10

Journal of the European Academy of Dermatology and Venereology, 2021-08, Vol.35 (8), p.e524-e526

2021

Volltextzugriff (PDF)

A sharp increase in early syphilis cases in a referral hospital in Athens, Greece, 2 years into the COVID-19 pandemic

Journal of the European Academy of Dermatology and Venereology, 2024-06, Vol.38 (6), p.e450-e452

2024

Volltextzugriff (PDF)

How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules

Human vaccines & immunotherapeutics, 2021-11, Vol.17 (11), p.4105-4107

2021

Volltextzugriff (PDF)

The effect of anxiety, psychopathological symptoms and personality traits on response to treatment in male patients with anogenital warts: a prospective study

Journal of the European Academy of Dermatology and Venereology, 2021-09, Vol.35 (9), p.1859-1864

2021

Volltextzugriff (PDF)

Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra‐patient, left‐to‐right prospective study

Journal of the European Academy of Dermatology and Venereology, 2020-09, Vol.34 (9), p.e519-e520

2020

Volltextzugriff (PDF)

Hyperpigmentation and melasma

Journal of cosmetic dermatology, 2007-09, Vol.6 (3), p.195-202

2007

Volltextzugriff (PDF)

First update of the living European guideline (EuroGuiDerm) on atopic eczema

Journal of the European Academy of Dermatology and Venereology, 2023-11, Vol.37 (11), p.e1283-e1287

2023

Volltextzugriff (PDF)

Topical steroids for the treatment of retronychia

Journal of the European Academy of Dermatology and Venereology, 2019-09, Vol.33 (9), p.e320-e322

2019

Volltextzugriff (PDF)

Herpetic whitlow mimicking squamous cell carcinoma in an immunocompromised patient

Journal of the European Academy of Dermatology and Venereology, 2020-02, Vol.34 (2), p.e51-e53

2020

Volltextzugriff (PDF)

Isotretinoin-induced transverse leuconychia

Journal of the European Academy of Dermatology and Venereology, 2016-02, Vol.30 (2), p.385-386

2016

Volltextzugriff (PDF)

Managing pitted keratolysis: consider topical glycopyrrolate

Clinical and experimental dermatology, 2019-08, Vol.44 (6), p.713-714

2019

Volltextzugriff (PDF)

Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study

Dermatology (Basel), 2011-01, Vol.223 (4), p.325

2011

Volltextzugriff (PDF)

Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study

British journal of dermatology (1951), 2008-08, Vol.159 (2), p.453-456

2008

Volltextzugriff (PDF)

Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial

British journal of dermatology (1951), 2004-11, Vol.151 (5), p.1071-1075

2004

Volltextzugriff (PDF)

Treatment of nail psoriasis with adalimumab: an open label unblinded study

Journal of the European Academy of Dermatology and Venereology, 2010-05, Vol.24 (5), p.530-534

2010

Volltextzugriff (PDF)

Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study

British journal of dermatology (1951), 2009-04, Vol.160 (4), p.858-860

2009

Volltextzugriff (PDF)

1 – 25 von 1.570

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(813)
Mit Volltextzugriff
(1.234)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Environmental assessment of an integrated adaptive system for the improvement of indoor visual comfort of existing buildings

Omalizumab for the management of refractory aquagenic pruritus

Pharmacokinetic profile data of glycopyrronium bromide 1% cream beyond 2 weeks are important

BP-180-specific IgG antibodies: A potential useful candidate for early diagnosis of Bullous pemphigoid during anti-PD-1/anti-PDL-1 of melanoma patients

‘COVID vaccine arm’ may present after both mRNA vaccines vaccination

Treatment of male genital lichen sclerosus with heterologous type I collagen

Treatment of nail psoriasis with brodalumab: an open‐label unblinded study

Stress and melanoma. Myth or reality?

Management Strategies Of Palmar Hyperhidrosis: Challenges And Solutions

Treatment of primary axillary hyperhidrosis with a cream formulation of oxybutynin chloride 10

A sharp increase in early syphilis cases in a referral hospital in Athens, Greece, 2 years into the COVID-19 pandemic

How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules

The effect of anxiety, psychopathological symptoms and personality traits on response to treatment in male patients with anogenital warts: a prospective study

Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra‐patient, left‐to‐right prospective study

Hyperpigmentation and melasma

First update of the living European guideline (EuroGuiDerm) on atopic eczema

Topical steroids for the treatment of retronychia

Herpetic whitlow mimicking squamous cell carcinoma in an immunocompromised patient

Isotretinoin-induced transverse leuconychia

Managing pitted keratolysis: consider topical glycopyrrolate

Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study

Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study

Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial

Treatment of nail psoriasis with adalimumab: an open label unblinded study

Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study

Suchergebnisse filtern